OrbiMed — funds, providers and filings
Managers: all tracked managers · fund search & entity graph · private market performance
Registrations
- 2026-05-22 New fund vehicle registered: OrbiMed Asia Partners IV, L.P. (KY) entity register
- 2026-05-22 New fund vehicle registered: OrbiMed Private Investments VIII, LP (US-DE) entity register
- 2026-05-12 New fund vehicle registered: ORBIMED PRIVATE INVESTMENTS X, LP (US-DE) entity register
- 2026-05-12 New fund vehicle registered: ORBIMED ROYALTY & CREDIT OPPORTUNITIES V OFFSHORE, LP (US-DE) entity register
- 2026-05-12 New fund vehicle registered: ORBIMED ROYALTY & CREDIT OPPORTUNITIES V, LP (US-DE) entity register
OrbiMed is a healthcare-focused investment firm. It invests worldwide, from start-ups to large companies. It runs private equity, public equity, and royalty and credit funds across the health industry. (OrbiMed)
Asset classes
The range spans healthcare public equity, private equity and royalty and credit.
Fund structure
Its funds are organised into 1 feeder funds.
The US-reported view
The sections below draw on US regulatory filings — SEC Form ADV and Form D — and on US investors' own disclosures. They set out OrbiMed's US-reported slice: the funds, service providers, domiciles and activity visible in US filings, not its worldwide business.
1. US-SEC private funds
This page reports $18.2bn of gross asset value across 31 private funds that OrbiMed reports on SEC Form ADV, filings through 2024. Its firm-wide figures are in the Assets summary at the top of this page, measured on a different basis.
Worldwide, 9 registered fund vehicles are on file under its management companies, on the worldwide entity register (read 2026-10-05) — these are legal fund entities, not the share classes or products a manager markets.
| Registered fund vehicles worldwide (as at 2026-10-05) | 9 |
| Management entities on file (US filings · worldwide register) | 2 · 1 |
| Principal offices on file | New York, United States |
2. Service providers
KPMG audits 30 of the 31 OrbiMed funds that name an auditor on Form ADV Schedule D, filings through 2024 — more than any other firm. SS&C administers 17 of the 27 that name an administrator, on the same filings. Relationships the filings attribute to OrbiMed's own group are part of its structure, not third-party appointments, and are left out of these counts.
Across the funds that disclose each role on Schedule D — the count is funds naming that provider, of funds disclosing the role at all:
| Fund administrator | SS&C (17 of 27); Hedgeserv (Cayman) LTD. (10 of 27) |
| Auditor | KPMG (30 of 31); Brightman Almagor Zohar & Co. (2 of 31) |
| Custodian | J.P. Morgan (24 of 31); Silicon Valley Bank (22 of 31); Merrill Lynch (10 of 31) — and 15 more |
| Prime broker | Goldman Sachs (7 of 5); J.P. Morgan (5 of 5) |
| Marketer / placement | Far Hills Group, LLC. (5 of 10); J.P. Morgan (5 of 10); Wells Fargo (2 of 10) — and 1 more |
3. Fund domiciles
18 of OrbiMed's 31 SEC-reported private funds are domiciled in Delaware, its largest single domicile on Form ADV, filings through 2024. Cayman Islands is next, and the bars below give the rest in order.
4. Fund filing activity
OrbiMed Private Investments X, LP is the largest US raise on file for an OrbiMed fund: $1.7bn sold to date, on its 2026 Form D filing. Amounts are cumulative sold-to-date figures as filed. They cover a fund's life up to that filing, not a single fundraise, and a fund that raises outside the US files nothing here.
The largest of the 3 US private-fund filings for OrbiMed's funds, by amount sold to date as filed.
| Issuer | Type | Amount sold (as filed) | Filing year | Source |
|---|---|---|---|---|
| OrbiMed Private Investments X, LP | Private Equity Fund | $1.7bn | 2026 | filing |
| OrbiMed Asia Partners VI, L.P. | Private Equity Fund | $534m | 2026 | filing |
| OrbiMed Genesis Fund, Ltd. | Hedge Fund | $146m | 2026 | filing |
5. Fund performance
Every figure here is a disclosing pension plan's own, on that plan's own reporting date. Nothing is blended into a manager-level return, because no plan published one.
Per-fund net IRR, multiple and DPI as disclosed by the pension plans invested in the funds — the LPs' own numbers, on their own dates, not the manager's. One row per plan disclosure. Where two plans hold the same fund and report different numbers, both rows show, with their dates:
| Fund | Plan | Net IRR | Multiple | DPI | Reported as at | Source |
|---|---|---|---|---|---|---|
| OrbiMed Royalty Credit Opps V | CalSTRS | 0.0% | — | — | 30 June 2025 | CalSTRS private equity performance report |
| OrbiMed Private Investments IX LP | CalSTRS | 24.1% | 1.26 | 0.28 | 30 June 2025 | CalSTRS private equity performance report |
| OrbiMed Royalty Credit Opps IV | CalSTRS | 13.2% | 1.11 | 0.58 | 30 June 2025 | CalSTRS private equity performance report |
| OrbiMed Private Investments VIII LP | CalSTRS | 6.9% | 1.19 | 0.3 | 30 June 2025 | CalSTRS private equity performance report |
| OrbiMed Royalty & Credit Opportunities III, LP | CalSTRS | 15.1% | 1.2 | 0.95 | 30 June 2025 | CalSTRS private equity performance report |
| OrbiMed Private Investments VI | Oregon OPERF | 14.1% | 1.76 | 1.22 | 31 March 2026 | Oregon Treasury OPERF private equity portfolio |
| OrbiMed Private Investments V | CalSTRS | 38.2% | 2.45 | 2.25 | 30 June 2025 | CalSTRS private equity performance report |
| OrbiMed Private Investments V | Oregon OPERF | 38.2% | 2.38 | 2.14 | 31 March 2026 | Oregon Treasury OPERF private equity portfolio |
| OrbiMed Private Investments IV, L.P. | CalSTRS | 31.8% | 3.12 | 3.05 | 30 June 2025 | CalSTRS private equity performance report |
| OrbiMed Private Investments IV, L.P. | Oregon OPERF | 31.8% | 2.73 | 2.73 | 31 March 2026 | Oregon Treasury OPERF private equity portfolio |
Young vintages sit in the J-curve: an early negative IRR mostly reflects fees drawn before value is realised, and is not a verdict on the fund.
6. Known LP investors, from their own disclosures
CalSTRS (7), Oregon OPERF (3) — the count is this manager's funds appearing in that plan's disclosure.
7. Management entities
OrbiMed files Form ADV through 2 management entities; the largest is Orbimed Advisors LLC, CRD 118608 of New York, with 30 of the 31 funds on this page. Every figure above rolls those filers up into one business. The table below traces each of them back to the entity that filed it, so a number can be checked against its own record rather than taken on trust.
US management entities on file (2 entities — together the 31 funds above)
| Entity | SEC CRD | City | Funds of the 31 |
|---|---|---|---|
| Orbimed Advisors LLC | CRD 118608 | New York | 30 |
| Orbimed Capital LLC | CRD 120188 | New York | 1 |
Management entities on the worldwide register (1 entities — together the 9 registered vehicles)
| Entity | Register ID | Fund vehicles |
|---|---|---|
| Orbimed Advisors LLC | 57G4FX4JA0RP0CHYJ782 | 9 |
8. Similar managers
Questions this page answers
What is OrbiMed's AUM?
Across the group it managed $20 billion in 2026. (OrbiMed). It also reports $18.2bn of gross asset value across 31 private funds on its US SEC filings (Form ADV, through 2024).
Who audits OrbiMed's funds?
KPMG is named on 30 of the 31 US private funds whose filing discloses an auditor on Form ADV Schedule D (of OrbiMed's 31 filed with the SEC), filings through 2024. Brightman Almagor Zohar & Co. appears on 2 of the same filings.
Who administers OrbiMed's funds?
SS&C is named on 17 of the 27 US private funds whose filing discloses an administrator on Form ADV Schedule D (of OrbiMed's 31 filed with the SEC), filings through 2024. Hedgeserv (Cayman) LTD. appears on 10 of the same filings.
How have OrbiMed's funds performed?
OrbiMed Private Investments IV, L.P. returned a net IRR of 31.8% on a 2.73 multiple, as Oregon OPERF reported it for 31 March 2026. OrbiMed Private Investments V returned a net IRR of 38.2% on a 2.38 multiple, as Oregon OPERF reported it for 31 March 2026.
Who invests in OrbiMed's funds?
CalSTRS (7 funds) and Oregon OPERF (3 funds) name OrbiMed funds in their published disclosures. Coverage is limited to the plans this site follows, and a plan's absence says nothing about whether it invests.
How many funds does OrbiMed run?
OrbiMed has 9 registered fund vehicles on the worldwide entity register — legal fund entities, not the share classes or products a manager markets. Separately, it reports 31 private funds to the US SEC (Form ADV, through 2024) — a different register, counted on a different basis.
Where are OrbiMed's funds domiciled?
18 of the 31 funds are domiciled in Delaware, its largest single domicile on Form ADV, filings through 2024, followed by Cayman Islands with 10.
Where does OrbiMed file from?
Orbimed Advisors LLC, CRD 118608, its largest Form ADV filer, gives its office as New York, United States. The other filers' offices are in the entity table on this page.
Is OrbiMed registered with the SEC?
Yes. Its filings run through 2 management entities, the largest being Orbimed Advisors LLC, CRD 118608, with 30 of the 31 funds here.
See also: all tracked managers · fund search & entity graph.